[go: up one dir, main page]

GB9025710D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9025710D0
GB9025710D0 GB909025710A GB9025710A GB9025710D0 GB 9025710 D0 GB9025710 D0 GB 9025710D0 GB 909025710 A GB909025710 A GB 909025710A GB 9025710 A GB9025710 A GB 9025710A GB 9025710 D0 GB9025710 D0 GB 9025710D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909025710A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB909025710A priority Critical patent/GB9025710D0/en
Publication of GB9025710D0 publication Critical patent/GB9025710D0/en
Priority to EP92902524A priority patent/EP0559812A1/fr
Priority to PCT/GB1991/002063 priority patent/WO1992009286A1/fr
Priority to PL91299319A priority patent/PL168421B1/pl
Priority to AU89098/91A priority patent/AU659422B2/en
Priority to CA002096962A priority patent/CA2096962A1/fr
Priority to JP4500445A priority patent/JPH06502855A/ja
Priority to ZA919290A priority patent/ZA919290B/xx
Priority to IE409191A priority patent/IE914091A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB909025710A 1990-11-27 1990-11-27 Novel treatment Pending GB9025710D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB909025710A GB9025710D0 (en) 1990-11-27 1990-11-27 Novel treatment
EP92902524A EP0559812A1 (fr) 1990-11-27 1991-11-21 Composition renfermant des inhibiteurs des recepteurs h 2? a l'histamine ainsi qu'un materiau a adhesion biologique
PCT/GB1991/002063 WO1992009286A1 (fr) 1990-11-27 1991-11-21 Composition renfermant des inhibiteurs des recepteurs h2 a l'histamine ainsi qu'un materiau a adhesion biologique
PL91299319A PL168421B1 (en) 1990-11-27 1991-11-21 Method of obtaining a pharmaceutic composition for treating stomach disorders
AU89098/91A AU659422B2 (en) 1990-11-27 1991-11-21 Composition containing antihistamine H2 receptor antagonists and bioadhesive material
CA002096962A CA2096962A1 (fr) 1990-11-27 1991-11-21 Composition contenant des antagonistes du recepteur h2 de l'histamine et materiau bioadhesif
JP4500445A JPH06502855A (ja) 1990-11-27 1991-11-21 抗ヒスタミンｈ↓２受容体拮抗剤および生体接着剤を含有する組成物
ZA919290A ZA919290B (en) 1990-11-27 1991-11-25 Composition containing antihistamine h2 receptor antagonists and bioadhesive material
IE409191A IE914091A1 (en) 1990-11-27 1991-11-25 Novel treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909025710A GB9025710D0 (en) 1990-11-27 1990-11-27 Novel treatment

Publications (1)

Publication Number Publication Date
GB9025710D0 true GB9025710D0 (en) 1991-01-09

Family

ID=10686017

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909025710A Pending GB9025710D0 (en) 1990-11-27 1990-11-27 Novel treatment

Country Status (9)

Country Link
EP (1) EP0559812A1 (fr)
JP (1) JPH06502855A (fr)
AU (1) AU659422B2 (fr)
CA (1) CA2096962A1 (fr)
GB (1) GB9025710D0 (fr)
IE (1) IE914091A1 (fr)
PL (1) PL168421B1 (fr)
WO (1) WO1992009286A1 (fr)
ZA (1) ZA919290B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
WO1995001784A1 (fr) * 1993-07-06 1995-01-19 Merck & Co., Inc. Composes anti-flatulences a base d'antagoniste d'h2 et de sucralfate
WO1995010274A1 (fr) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Composition pharmaceutique aqueuse
GB9407235D0 (en) * 1994-04-12 1994-06-08 Glaxo Group Ltd Pharmaceutical compositions
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
KR19980703526A (ko) * 1995-04-03 1998-11-05 나가야마오사무 수크랄페이트 함유 제제 조성물
WO1997028823A1 (fr) * 1996-02-08 1997-08-14 Chugai Seiyaku Kabushiki Kaisha Procede d'utilisation d'un agent antiacide et preparation pharmaceutique le contenant
EP1074259A4 (fr) * 1998-04-01 2001-06-27 Chugai Pharmaceutical Co Ltd Medicaments preventifs des gastrites alcooliques
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
EP4522122A1 (fr) * 2022-05-09 2025-03-19 SYRI Research Private Limited Formulation orale liquide de famotidine ou d'un sel pharmaceutiquement acceptable de celle-ci

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
US4975281A (en) * 1989-01-30 1990-12-04 E. R. Squibb & Sons, Inc. Anti-ulcer composition
EP0403048A3 (fr) * 1989-06-14 1991-01-30 Warner-Lambert Company Un modèle de structure de système craniomandibulaire humain

Also Published As

Publication number Publication date
PL168421B1 (en) 1996-02-29
IE914091A1 (en) 1992-06-03
ZA919290B (en) 1992-09-30
WO1992009286A1 (fr) 1992-06-11
JPH06502855A (ja) 1994-03-31
CA2096962A1 (fr) 1992-05-28
AU659422B2 (en) 1995-05-18
EP0559812A1 (fr) 1993-09-15
AU8909891A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
GB9127150D0 (en) Novel treatment
GB9215633D0 (en) Novel treatment
GB9211148D0 (en) Novel treatment
GB9225860D0 (en) Novel treatment
GB9025710D0 (en) Novel treatment
GB9024928D0 (en) Novel treatment
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9024926D0 (en) Novel treatment
GB9024925D0 (en) Novel treatment
GB9007734D0 (en) Novel treatment
GB9005212D0 (en) Novel treatment
GB9018676D0 (en) Novel treatment
GB9014242D0 (en) Novel treatment
GB9013910D0 (en) Novel treatment
GB9013268D0 (en) Novel treatment
GB9010298D0 (en) Novel treatment
GB9022537D0 (en) Novel treatment
GB9010163D0 (en) Novel treatment i
GB9022298D0 (en) Treatment composition
GB9004545D0 (en) Novel treatment iii
GB9020697D0 (en) Treatment
GB9009388D0 (en) Treatment
GB9014981D0 (en) New treatment
GB9112720D0 (en) Novel treatment